Paul Chun

Goldman Sachs & Co. LLC (GS&Co.) is a securities brokerage firm headquartered in New York City. Founded in 1927, the firm is a subsidiary of The Goldman Sachs Group, Inc. (NYSE: GS). GS&Co. provides services to help hedge funds manage risk, monitor portfolios, maintain liquidity and build their businesses. They offer clients access to global equity and derivatives markets, as well as foreign exchange, commodities, European Lefts, rates and credit across the Americas, Europe and Asia. The firm proactively monitors capital markets, searching for pockets of liquidity and news that may require changes to those strategies. Integration with the Goldman Sachs network gives clients access to the firm's sectored block trades and their insights into price discovery. Their electronic trading program provides clients with tools to manage their trades from pre-trade analytics to post-trade analysis.

Tavistock Life Sciences Co (Tavistock Life Sciences Co.) is a venture capital firm founded in 2002. The firm is headquartered in San Diego, California.

Amgen Ventures LLC (Amgen Ventures) is a venture capital firm, a subsidiary of Amgen, Inc. founded in 2004. The firm is headquartered in Thousand Oaks, California.

Stellar Biotechnologies, Inc. engages in the research, development, manufacture, and commercialization of Keyhole Limpet Hemocyanin (KLH), an immune-stimulating protein utilized as a carrier molecule in therapeutic vaccines and for assessing immune system function. Its product portfolio includes Stellar KLH Products, Stellar KLH Protein, and Stellar KLH ELISA Kits. The Company was founded in 1999 and is headquartered in Port Hueneme, CA.

Westwicke Partners LLC operates as a strategic communications and advisory firm that is focused exclusively on healthcare. It offers digital branding, crisis communications, and capital markets advisory. The company was founded by Robert East and Mark Klausner in 2006 and is headquartered in Baltimore, MD.

Kiromic LLC is a target discovery and American gene-editing company that focuses on utilizing an artificial intelligence platform to unleash the power of the patient's own immune system to fight cancer. The private company is based in Lubbock. The company's proprietary target discovery artificial intelligence engine called "Diamond" is used to leverage pipeline development.